Coronavirus: Johnson & Johnson to produce 1 billion vaccines



[ad_1]

Dr. Paul Stoffels, Scientific Director of Johnson & Johnson, assured that, due to the rapid expansion of the Covid-19 worldwide, Finding an urgent vaccine is vital.

For that reason, he assured that they will produce 1 billion coronavirus vaccines to deliver in 2021.

“Clinical trials begin in September with the goal of delivering 1 billion vaccines next year,” he told ABC News.

Read also: Bolsonaro compares isolation measures with the crisis in Venezuela

He also indicated that they could have a vaccine ready this year. However, he clarified that only the authorities can decide to use it before they are ready. efficacy tests.

On the other hand, the prestigious company explained that under normal circumstances, the creation of a vaccine could take between five and seven years. However, given the seriousness of the situation, they indicated that they are working intensively to achieve immediate results.

Currently the government of United States is collaborating with the project of Johnson & Johnson. Donald trump awarded about $ 500 million to make rapid advances in research.

The other hope

The Israel Institute for Biotechnology Research, under the Ministry of Defense, recently announced that it has developed an antibody to the coronavirus, which is preparing the patent registration and which will soon contact pharmaceutical companies to produce it on a commercial scale.

Also read: Israel develops antibody to coronavirus

In a joint statement with Defense, the research center ensures that the Developed antibody attacks the virus in patients and neutralizes it.

“According to Institute researchers, led by Professor Shmuel Shapiro, the antibody development phase has ended

Israeli Defense Minister Naftali Benet visited the institute’s laboratory in Ness Ziona, south of Tel Aviv, where they showed him the antibody, “that attacks the virus monoclonally, “and called this finding” an amazing achievement.

[ad_2]